This Beat episode, featuring Joel Dunning, MD, focuses on survivors' longitudinal functional status of ECMO after COVID-19, a trial on advanced reperfusion strategies, an analysis on the decrease in all adult surgeries, and results of robotically-assisted congenital cardiac surgery. For more information on this episode's topics, links are provided: What Does Survival Look Like After ECMO for COVID-19? Small registry highlights need to analyze survivors' longitudinal functional status https://www.medpagetoday.com/meetingcoverage/sts/90972 Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial https://www.thelancet.com/article/S0140-6736(20)32338-2/fulltext An analysis of national data revealed a 53% decrease in all adult heart surgeries, including a 40% decline in non-elective heart surgeries and a 65% drop in elective heart surgeries during the pandemic, compared to 2019. https://consumer.healthday.com/b-2-2-pandemic-has-cut-heart-surgeries-in-half-and-more-patients-are-dying-2650177681.html    https://www.ctsnet.org/article/totally-endoscopic-transaortic-septal-myectomy-hypertrophic-cardiomyopathy Early Results of Robotically Assisted Congenital Cardiac Surgery: Analysis of 242 Patients : JANS posting https://www.ctsnet.org/jans/early-results-robotically-assisted-congenital-cardiac-surgery-analysis-242-patients

In this CTSNet To Go podcast episode, Niv Ad moderates a discussion on the importance of atrial fibrillation in decision-making in structural heart disease and coronary artery disease. He is joined by Marc Gerdisch of the Franciscan St. Francis Heart Center in Indianapolis, Indiana, USA; Joanna Chikwe of Cedars Sinai Medical Center in Los Angeles, California, USA;  and Vinod Thourani of the Piedmont Heart Institute in Atlanta, Georgia, USA.